Keywords
Last Name
Institution

LEONARD E WEISMAN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
AddressONE BAYLOR PLAZA
HOUSTON TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pammi M, Weisman LE. Late-onset sepsis in preterm infants: update on strategies for therapy and prevention. Expert Rev Anti Infect Ther. 2015 Apr; 13(4):487-504. PMID: 25661566.
      View in: PubMed
    2. Munoz FM, Weisman LE, Read JS, Siberry G, Kotloff K, Friedman J, Higgins RD, Hill H, Seifert H, Nesin M. Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy. Clin Infect Dis. 2014 Dec 15; 59 Suppl 7:S415-27. PMID: 25425720; PMCID: PMC4303057.
    3. Weisman LE, Leeming AH, Kong L. Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse. Pediatr Res. 2012 Nov; 72(5):502-6. PMID: 22907617.
      View in: PubMed
    4. Pammi M, Eddama O, Weisman LE. Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units. Cochrane Database Syst Rev. 2011; (11):CD006068. PMID: 22071827.
      View in: PubMed
    5. Lin FY, Weisman LE, Azimi P, Young AE, Chang K, Cielo M, Moyer P, Troendle JF, Schneerson R, Robbins JB. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J. 2011 Sep; 30(9):759-63. PMID: 21540758; PMCID: PMC3158245.
    6. Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KG, Trautman MS, Escobedo M, Meissner HC, Sasidharan P, Fretz J, Kokai-Kun JF, Kramer WG, Fischer GW, Mond JJ. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug; 128(2):271-9. PMID: 21788224.
      View in: PubMed
    7. Walls SA, Kong L, Leeming HA, Placencia FX, Popek EJ, Weisman LE. Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice. Pediatr Res. 2009 Aug; 66(2):197-202. PMID: 19390479.
      View in: PubMed
    8. Weisman LE. Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future. Cardiovasc Hematol Agents Med Chem. 2009 Jul; 7(3):223-33. PMID: 19689261.
      View in: PubMed
    9. Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, Kokai-Kun JF, Mond JJ, Kramer WG, Fischer GW. Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates. Antimicrob Agents Chemother. 2009 Jul; 53(7):2879-86. PMID: 19380597; PMCID: PMC2704668.
    10. Weisman LE. Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations. Curr Opin Mol Ther. 2009 Apr; 11(2):208-18. PMID: 19330726.
      View in: PubMed
    11. Placencia FX, Kong L, Weisman LE. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin. Pediatr Res. 2009 Apr; 65(4):420-4. PMID: 19127212.
      View in: PubMed
    12. Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Kramer WG, Mond JJ. Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults. Int Immunopharmacol. 2009 May; 9(5):639-44. PMID: 19268719.
      View in: PubMed
    13. Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, Philips JB, Weisman LE, Rhoads GG, Lin FY. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol. 2008 Apr; 46(4):1285-91. PMID: 18287314; PMCID: PMC2292926.
    14. Weisman LE. Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literature. Arch Pediatr. 2007 Sep; 14 Suppl 1:S31-4. PMID: 17939955.
      View in: PubMed
    15. Venkatesh MP, Pham D, Kong L, Weisman LE. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection. Adv Ther. 2007 Sep-Oct; 24(5):941-54. PMID: 18029319.
      View in: PubMed
    16. Mohan P, Eddama O, Weisman LE. Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units. Cochrane Database Syst Rev. 2007; (3):CD006068. PMID: 17636825.
      View in: PubMed
    17. Oluola O, Kong L, Fein M, Weisman LE. Lysostaphin in treatment of neonatal Staphylococcus aureus infection. Antimicrob Agents Chemother. 2007 Jun; 51(6):2198-200. PMID: 17420212; PMCID: PMC1891369.
    18. Venkatesh MP, Pham D, Fein M, Kong L, Weisman LE. Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth. Antimicrob Agents Chemother. 2007 Apr; 51(4):1240-5. PMID: 17261622; PMCID: PMC1855490.
    19. Venkatesh MP, Placencia F, Weisman LE. Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis. 2006 Jul; 17(3):120-7. PMID: 16934706.
      View in: PubMed
    20. Lin FY, Whiting A, Adderson E, Takahashi S, Dunn DM, Weiss R, Azimi PH, Philips JB, Weisman LE, Regan J, Clark P, Rhoads GG, Frasch CE, Troendle J, Moyer P, Bohnsack JF. Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J Clin Microbiol. 2006 Apr; 44(4):1257-61. PMID: 16597848; PMCID: PMC1448625.
    21. Venkatesh MP, Weisman LE. Prevention and treatment of respiratory syncytial virus infection in infants: an update. Expert Rev Vaccines. 2006 Apr; 5(2):261-8. PMID: 16608425.
      View in: PubMed
    22. Weisman LE. Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient. Curr Opin Infect Dis. 2004 Jun; 17(3):237-41. PMID: 15166827.
      View in: PubMed
    23. Lin FY, Weisman LE, Troendle J, Adams K. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis. 2003 Jul 15; 188(2):267-71. PMID: 12854082.
      View in: PubMed
    24. O'Donovan DJ, Baetiong A, Adams K, Chen A, Smith EO, Adams JM, Weisman LE. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol. 2003 Jun; 23(4):286-90. PMID: 12774134.
      View in: PubMed
    25. Weisman L. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S33-7; discussion S37-9. PMID: 12671450.
      View in: PubMed
    26. Lin FY, Philips JB, Azimi PH, Weisman LE, Clark P, Rhoads GG, Regan J, Concepcion NF, Frasch CE, Troendle J, Brenner RA, Gray BM, Bhushan R, Fitzgerald G, Moyer P, Clemens JD. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis. 2001 Oct 15; 184(8):1022-8. PMID: 11574917.
      View in: PubMed
    27. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB, Regan JA, Clark P, Weisman LE, Rhoads GG, Kong F, Clemens JD. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001 May; 184(6):1204-10. PMID: 11349189.
      View in: PubMed
    28. Lin FY, Azimi PH, Weisman LE, Philips JB, Regan J, Clark P, Rhoads GG, Clemens J, Troendle J, Pratt E, Brenner RA, Gill V. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis. 2000 Jul; 31(1):76-9. PMID: 10913400.
      View in: PubMed
    29. Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J. 1999 Mar; 18(3):223-31. PMID: 10093942.
      View in: PubMed
    30. Perez EM, Cooper TR, Moise AA, Ferry GD, Weisman LE. Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report. J Perinatol. 1998 Jul-Aug; 18(4):317-9. PMID: 9730206.
      View in: PubMed
    31. Cooper TR, Berseth CL, Adams JM, Weisman LE. Actuarial survival in the premature infant less than 30 weeks' gestation. Pediatrics. 1998 Jun; 101(6):975-8. PMID: 9606222.
      View in: PubMed
    32. Lin FY, Clemens JD, Azimi PH, Regan JA, Weisman LE, Philips JB, Rhoads GG, Clark P, Brenner RA, Ferrieri P. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis. 1998 Mar; 177(3):790-2. PMID: 9498466.
      View in: PubMed
    33. Subramanian KN, Weisman LE, Rhodes T, Ariagno R, Sánchez PJ, Steichen J, Givner LB, Jennings TL, Top FH, Carlin D, Connor E. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J. 1998 Feb; 17(2):110-5. PMID: 9493805.
      View in: PubMed
    34. Adams JM, Moreno J, Reynolds K, Campbell DW IV, Smith EO, Weisman LE. Resource utilization among neonatologists in a university children's hospital. Pediatrics. 1997 Jun; 99(6):E2. PMID: 9164798.
      View in: PubMed
    35. Perez EM, Weisman LE. Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol. 1997 Mar; 24(1):213-29. PMID: 9099511.
      View in: PubMed
    36. Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol. 1996 Oct; 20(5):375-80. PMID: 8912991.
      View in: PubMed
    37. McCurdy FA, Weisman LE. Teaching newborn medicine to third-year medical students. Use of a checklist. Arch Pediatr Adolesc Med. 1995 Jan; 149(1):49-52. PMID: 7827660.
      View in: PubMed
    38. Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, Subramanian KN, Hankins CT, Cruess DF, Hemming VG, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr. 1994 Dec; 125(6 Pt 1):922-30. PMID: 7996367.
      View in: PubMed
    39. Weisman LE, Cruess DF, Fischer GW. Opsonic activity of commercially available standard intravenous immunoglobulin preparations. Pediatr Infect Dis J. 1994 Dec; 13(12):1122-5. PMID: 7892082.
      View in: PubMed
    40. Weisman LE. Advances in the treatment of neonatal sepsis and meningitis. Isr J Med Sci. 1994 May-Jun; 30(5-6):455-8. PMID: 8034503.
      View in: PubMed
    41. Fischer GW, Cieslak TJ, Wilson SR, Weisman LE, Hemming VG. Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin. J Infect Dis. 1994 Feb; 169(2):324-9. PMID: 8106765.
      View in: PubMed
    42. Beachy JC, Weisman LE. Acute asphyxia affects neutrophil number and function in the rat. Crit Care Med. 1993 Dec; 21(12):1929-34. PMID: 8252900.
      View in: PubMed
    43. Weisman LE, Cruess DF, Fischer GW. Standard versus hyperimmune intravenous immunoglobulin in preventing or treating neonatal bacterial infections. Clin Perinatol. 1993 Mar; 20(1):211-24. PMID: 8458166.
      View in: PubMed
    44. Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, Fischer GW. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr. 1992 Sep; 121(3):428-33. PMID: 1517922.
      View in: PubMed
    45. Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, Subramanian KN, Hankins CT, Anthony BF, Cruess DF, et al. Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr. 1992 Sep; 121(3):434-43. PMID: 1517923.
      View in: PubMed
    46. Weisman LE, Cruess DF, Fischer GW. Current status of intravenous immunoglobulin in preventing or treating neonatal bacterial infections. Clin Rev Allergy. 1992 Spring-Summer; 10(1-2):13-28. PMID: 1606520.
      View in: PubMed
    47. Fischer GW, Weisman LE, Hemming VG. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review. Clin Immunol Immunopathol. 1992 Jan; 62(1 Pt 2):S92-7. PMID: 1728993.
      View in: PubMed
    48. Weisman LE, Dobson FM. The potential impact of group B streptococcal antibodies in breast milk. Adv Exp Med Biol. 1991; 310:345-51. PMID: 1809009.
      View in: PubMed
    49. Fischer GW, Weisman LE. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics. Scand J Infect Dis Suppl. 1990; 73:17-21. PMID: 2128662.
      View in: PubMed
    50. Heiman HS, Weisman LE. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity. Vet Immunol Immunopathol. 1990 Jan; 24(1):79-89. PMID: 2180204.
      View in: PubMed
    51. Weisman LE, McKinney L, Villalobos R. Systemic group B streptococcal disease in the neonate: characterization of an oral colonization model using the suckling rat. Microbiol Immunol. 1990; 34(9):755-64. PMID: 2149405.
      View in: PubMed
    52. Heiman HS, Weisman LE. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection. Pediatr Res. 1989 Dec; 26(6):629-32. PMID: 2689988.
      View in: PubMed
    53. Weisman LE, Lorenzetti PM. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. J Pediatr. 1989 Sep; 115(3):445-50. PMID: 2671331.
      View in: PubMed
    54. Weisman LE, Fischer GW, Marinelli P, Hemming VG, Pierce JR, Golden SM, Peck CC. Pharmacokinetics of intravenous immunoglobulin in neonates. Vox Sang. 1989; 57(4):243-8. PMID: 2694604.
      View in: PubMed
    55. Weisman LE, Fischer GW, Hemming VG, Peck CC. Pharmacokinetics of intravenous immunoglobulin (Sandoglobulin) in neonates. Pediatr Infect Dis. 1986 May-Jun; 5(3 Suppl):S185-8. PMID: 3520504.
      View in: PubMed
    56. Fischer GW, Hemming VG, Hunter KW, Gloser H, Bachmayer H, Von Pilar CE, Helting T, Weisman LE, Wilson SR, Baron PA. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies. Pediatr Infect Dis. 1986 May-Jun; 5(3 Suppl):S171-5. PMID: 3520501.
      View in: PubMed
    57. Hemming VG, Prince GA, Horswood RL, London WJ, Murphy BR, Walsh EE, Fischer GW, Weisman LE, Baron PA, Chanock RM. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985 Nov; 152(5):1083-7. PMID: 4045247.
      View in: PubMed
    58. Weisman LE, Merenstein GB, Steenbarger JR. The effect of lumbar puncture position in sick neonates. Am J Dis Child. 1983 Nov; 137(11):1077-9. PMID: 6637909.
      View in: PubMed
    WEISMAN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _